financetom
Business
financetom
/
Business
/
FuboTV's Request to Temporarily Block Disney-Fox-Warner Bros. Streaming Service Wins Court Approval
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FuboTV's Request to Temporarily Block Disney-Fox-Warner Bros. Streaming Service Wins Court Approval
Aug 19, 2024 4:10 AM

06:45 AM EDT, 08/19/2024 (MT Newswires) -- FuboTV ( FUBO ) shares jumped early Monday following a court ruling to temporarily block the launch of a rival sports streaming service platform backed by Walt Disney ( DIS ) , Fox (FOXA, FOX) and Warner Bros. Discovery ( WBD ) .

The US District Court for the Southern District of New York on Friday issued a preliminary injunction against the media giants' Venu Sports joint venture, citing their "near-monopolistic control" over the ability of an alternate sports streaming platform to exist in the market. The companies' control in the market will provide "powerful" incentives to "thwart competition and hike prices" on both consumers and other distributors, according to the court filing.

In February, Disney ( DIS ) subsidiary ESPN ( DIS ), Fox and Warner Bros. agreed on principal terms to jointly launch a new streaming platform offering content from various sporting leagues, events and tournaments. The platform, which was set to launch this fall for $42.99 per month, will combine the companies' sports network portfolios, certain direct-to-consumer sports services and sports rights.

FuboTV ( FUBO ) filed an antitrust lawsuit against the venture later in February, claiming the media companies "engaged in a years-long campaign to block" its sports-focused live-streaming business, resulting in "significant harm" to the company and its customers.

Fubo is "likely to be successful in proving its claims" that the joint venture will break antitrust laws and cause "irreplaceable harm" to the company and its US customers in the absence of an injunction, US District Judge Margaret Garnett said in the court ruling. The stay will remain in place until the completion of the legal proceedings. Shares of Fubo spiked 17% in premarket activity Monday.

"This decision will help ensure that consumers have access to a more competitive marketplace with multiple sports streaming options," Fubo Chief Executive David Gandler said in the Friday statement. "A fair and competitive marketplace is necessary to provide consumers with multiple, robust and more affordable sports streaming options."

The company aims to move forward with its lawsuit against the venture partners and their affiliates. A court date for the lawsuit hasn't been announced yet, according to Fubo.

Fox, Warner Bros. and Disney's ( DIS ) EPSN reportedly said they disagreed with the court decision and intend to appeal. They didn't immediately respond to MT Newswires' requests for comment.

Price: 1.8200, Change: +0.29, Percent Change: +18.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PJT Partners Q3 revenue up 37%, beats estimates
PJT Partners Q3 revenue up 37%, beats estimates
Nov 4, 2025
Overview * PJT Partners ( PJT ) Q3 revenue grows 37% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong financial performance * Company repurchased 2.3 mln shares, indicating confidence in future growth Result Drivers * STRATEGIC ADVISORY - Increase in strategic advisory revenues drove higher Q3 revenue * FUND PLACEMENT - Increase in fund placement...
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)
Nov 4, 2025
MELBOURNE, Australia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( PPCB ) (“Propanc” or the “Company”), a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced a strategic initiative to pursue the acquisition of Digital Asset Treasury (DAT) companies that are currently trading below their Market Cap to Net Asset Value (MNAV)....
Molson Coors Beverage Q3 Non-GAAP Earnings, Net Sales Decline
Molson Coors Beverage Q3 Non-GAAP Earnings, Net Sales Decline
Nov 4, 2025
06:58 AM EST, 11/04/2025 (MT Newswires) -- Molson Coors Beverage ( TAP/A ) reported Q3 non-GAAP earnings Tuesday of $1.67 per diluted share, up/down from $1.80 a year earlier. Analysts polled by FactSet expected $1.69. Net sales for the quarter ended Sept. 30 were $2.97 billion, down from $3.04 billion a year earlier. Analysts surveyed by FactSet expected $3.01 billion....
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
Nov 4, 2025
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 SOLANA BEACH, Calif., and VERO BEACH, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. ( EVOK ) (“Evoke”), a specialty pharmaceutical company focused primarily...
Copyright 2023-2026 - www.financetom.com All Rights Reserved